[18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics

This is the first clinical evaluation of [<sup>18</sup>F]SiTATE-PET/CT in patients with PPGL. MTV and TLU measured with [<sup>18</sup>F]SiTATE-PET/CT correlated well with the tumor marker chromogranin A in serum and with (nor)metanephrines in urine and plasma. Within the limits imposed by the small cohort, our results suggest that TLU and MTV in [<sup>18</sup>F]SiTATE-PET/CT could be used as SSTR imaging biomarker for monitoring of disease progression and secretory activity in patients with PPGL.

Authors

Institutions

Publication Details

Journal
European Journal of Nuclear Medicine and Molecular Imaging
Published
2025-05-29
DOI
https://doi.org/10.1007/s00259-025-07341-9
Citations
1
Primary Topic
Adrenal and Paraganglionic Tumors
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics

Thomas Pfluger, Martín Reincke, Christoph Josef Auernhammer, Júnia Ribeiro de Oliveira Longo Schweizer et al.
1 citations
European Journal of Nuclear Medicine and Molecular Imaging
Adrenal and Paraganglionic Tumors
2.01
article

[18F]SiTATE-PET/CT for detection of pheochromocytomas and paragangliomas: comparison of biochemical secretion, genotype and imaging metrics

Thomas Pfluger, Martín Reincke, Christoph Josef Auernhammer, Júnia Ribeiro de Oliveira Longo Schweizer, Christine Schmid‐Tannwald, Christian Lottspeich, Rudolf Alexander Werner, Alessa Fischer, Matthias Kroiß, Matthias Brendel, Friederike Völter, Katharina Wang, Martin Bidlingmaier, Nabeel Mansour, Matthias K. Auer, Svenja Nölting, Till Braunschweig, Alena Gesenhues, Sean Ira G. Gacula, Simon Lindner, Meike Onkes, Paul Dahlmann, Isabel Stüfchen, Franz‐Josef Gildehaus
article en
1 citations

Abstract

This is the first clinical evaluation of [<sup>18</sup>F]SiTATE-PET/CT in patients with PPGL. MTV and TLU measured with [<sup>18</sup>F]SiTATE-PET/CT correlated well with the tumor marker chromogranin A in serum and with (nor)metanephrines in urine and plasma. Within the limits imposed by the small cohort, our results suggest that TLU and MTV in [<sup>18</sup>F]SiTATE-PET/CT could be used as SSTR imaging biomarker for monitoring of disease progression and secretory activity in patients with PPGL.

European Journal of Nuclear Medicine and Molecular ImagingVol. 52(13)
German Cancer Research Center (DE), German Center for Neurodegenerative Diseases (DE), LMU Klinikum (DE), University Hospital of Zurich (CH), Munich Cluster for Systems Neurology (DE), National Kidney and Transplant Institute (PH), Ludwig-Maximilians-Universität München (DE)
Deutsche Forschungsgemeinschaft
Good health and well-being
Openalex Percentile: Top 15%
Adrenal and Paraganglionic Tumors
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.